Analyze Diet
Drug testing and analysis2022; 14(5); 902-914; doi: 10.1002/dta.3242

Identification of potential biomarkers in urine and plasma after consumption of tobacco product in horses.

Abstract: The use of nicotine stimulants in horses is generally banned in horse racing and equestrian sports-accidental consumption of tobacco products is one of the possible causes of nicotine exposure in horses. The authors recently reported a comprehensive metabolic study of nicotine in equines, differentiating between nicotine exposure and sample contamination by means of a nicotine biomarker trans-3'-hydroxycotinine. To identify potential biomarkers for the differentiation of genuine nicotine administration and consumption of tobacco products, tobacco leaves (equivalent to 250 mg of nicotine) were nasoesophageally administered to three thoroughbred mares. Quantification methods of anatabine in plasma and urine were newly developed and validated and successfully applied to postadministration samples. Previously reported simultaneous quantification methods of eight target analytes including nicotine and its metabolites in plasma and urine were also applied to the samples. The results demonstrate that both trans-3'-hydroxycotinine and anatabine could be used as potential biomarkers in equine urine and plasma to indicate recent exposure to tobacco products in horses. As well, trans-3'-hydroxycotinine had the longest half-life as a detectable metabolite in urine and plasma. To our knowledge, this is the first report of a comprehensive study of tobacco product detection in horses.
Publication Date: 2022-03-07 PubMed ID: 35195357DOI: 10.1002/dta.3242Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article explores the detection of nicotine consumption in horses by identifying potential biomarkers in the urine and plasma of horses who have ingested tobacco products.

Objective of the Study

  • The main aim of this research study is to distinguish between horses that have genuinely been administered nicotine and those that have accidentally consumed tobacco products. This differentiation is aimed at enhancing integrity and fairness in equestrian sports where nicotine stimulants are generally banned.

Experimental Process

  • The research team carried this out by administering tobacco leaves (equivalent to 250 mg of nicotine) nasoesophageally to three thoroughbred mares. So, the researchers were able to monitor the horses internally and accumulate direct data.
  • The research team also developed and validated new metrical methods to quantify anatabine in both plasma and urine samples collected from these horses post-administration.
  • Additionally, they applied previously proven simultaneous quantification methods that targeted eight key analytes, including nicotine and its metabolites, in plasma and urine samples.

Findings of the Research

  • The results of the study indicate that the biomarkers trans-3′-hydroxycotinine and anatabine found in equine urine and plasma could serve as potential indicators of recent exposure to tobacco products in horses.
  • The researchers also found that trans-3′-hydroxycotinine had the longest half-life as a detectable metabolite in both urine and plasma. This suggests that this metabolite could prove pivotal in monitoring the use of banned substances in equestrian sports.

Nature of the Study

  • It’s important to highlight that this appears to be the first comprehensive study of tobacco product detection in horses, laying the groundwork for profound advancements in controlling the use of performance-enhancing substances in equestrian sports.

Cite This Article

APA
Ishii H, Leung GN, Yamashita S, Nagata SI, Kushiro A, Sakai S, Toju K, Okada J, Kawasaki K, Kusano K, Kijima-Suda I. (2022). Identification of potential biomarkers in urine and plasma after consumption of tobacco product in horses. Drug Test Anal, 14(5), 902-914. https://doi.org/10.1002/dta.3242

Publication

ISSN: 1942-7611
NlmUniqueID: 101483449
Country: England
Language: English
Volume: 14
Issue: 5
Pages: 902-914

Researcher Affiliations

Ishii, Hideaki
  • Drug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
  • Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Miyagi, Japan.
Leung, Gary Ngai-Wa
  • Drug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
Yamashita, Shozo
  • Drug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
Nagata, Shun-Ichi
  • Genetic Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
Kushiro, Asuka
  • Equine Research Institute, Research Planning & Coordination Division, JRA, Shimotsuke, Tochigi, Japan.
Sakai, Satoshi
  • Race Horse Hospital, Miho Training Center, JRA, Inashiki-gun, Ibaraki, Japan.
Toju, Kota
  • Race Horse Hospital, Miho Training Center, JRA, Inashiki-gun, Ibaraki, Japan.
Okada, Jun
  • Veterinarian Section, Equine Department, JRA, Minato-ku, Tokyo, Japan.
Kawasaki, Kazumi
  • Veterinarian Section, Equine Department, JRA, Minato-ku, Tokyo, Japan.
Kusano, Kanichi
  • Race Horse Hospital, Ritto Training Center, JRA, Ritto, Shiga, Japan.
Kijima-Suda, Isao
  • Drug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.

MeSH Terms

  • Animals
  • Biomarkers / urine
  • Body Fluids / metabolism
  • Cotinine
  • Female
  • Horses
  • Nicotine
  • Plasma / metabolism
  • Tobacco Products

References

This article includes 22 references
  1. Kishioka S, Kiguchi N, Kobayashi Y, Saika F. Nicotine effects and the endogenous opioid system.. J Pharmacol Sci 2014;125(2):117-124.
    doi: 10.1254/jphs.14r03cpgoogle scholar: lookup
  2. Benowitz NL. Systemic absorption and effects of nicotine from smokeless tobacco.. Adv Dent Res 1997;11(3):336-341.
  3. Aktories K, Förstermann U, Hofmann FB, Starke K. Allgemeine Und Spezielle Pharmakologie Und Toxikologie.. Munich, Germany: Elsevier GmbH, Urban & Fischer Verlag; 2009.
  4. Morente-Sánchez J, Zandonai T, Mateo-March M. Acute effect of Snus on physical performance and perceived cognitive load on amateur footballers.. Scand J Med Sci Sports 2015;25(4):e423-e431.
    doi: 10.1111/sms.12321google scholar: lookup
  5. Chagué F, Guenancia C, Gudjoncik A, Moreau D, Cottin Y, Zeller M. Smokeless tobacco, sport and the heart.. Arch Cardiovasc Dis 2015;108(1):75-83.
  6. World Anti-Doping Agency. THE. 2012 MONITORING PROGRAM.. .
  7. Tretzel L, Thomas A, Piper T. Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing.. J Pharm Biomed Anal 2016;123:132-140.
  8. International Federation of Horseracing Authorities. International Agreement on Breeding, Racing And Wagering And Appendixes (January 2021).. .
  9. Fédération Équestre Internationale. 2021 Equine Prohibited Substances List.. .
  10. Soloway SB. Naturally occurring insecticides.. Environ Health Perspect 1976;14:109-117.
    doi: 10.1289/ehp.7614109google scholar: lookup
  11. Tomizawa M, Casida JE. Selective toxicity of neonicotinoids attributable to specificity of insect and mammalian nicotinic receptors.. Annu Rev Entomol 2003;48(1):339-364.
  12. Hukkanen J, Jacob P 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine.. Pharmacol Rev 2005;57(1):79-115.
    doi: 10.1124/pr.57.1.3google scholar: lookup
  13. Ishii H, Leung GN, Yamashita S. Comprehensive metabolic study of nicotine in equine plasma and urine using liquid chromatography/high-resolution mass spectrometry for the identification of unique biomarkers for doping control.. J Chromatogr B Anal Technol Biomed Life Sci 2022;1190:123100.
  14. Miller EI, Norris HR, Rollins DE, Tiffany ST, Wilkins DG. A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry.. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878(9-10):725-737.
  15. Vieira-Brock PL, Miller EI, Nielsen SM, Fleckenstein AE, Wilkins DG. Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometry.. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879(30):3465-3474.
  16. McGuffey JE, Wei B, Bernert JT. Validation of a LC-MS/MS method for quantifying urinary nicotine, six nicotine metabolites and the minor tobacco alkaloids-anatabine and anabasine-in smokers' urine.. PLoS One 2014;9(7):e101816.
  17. U.S. Department of Health and Human Services, Food and Drug Administration. Bioanalytical Method Validation Guidance for Industry.. .
  18. Europian Medicines Agency. Guideline on bioanalytical method validation.. .
  19. Ministry of Health, Labour and Welfare of Japan. Guideline on Bioanalytical Method Validation in Pharmaceutical Development.. .
  20. Blakely T, Bates M. Nicotine and Tar in Cigarette Tobacco: A Literature Review to Inform Policy Development, A Report for the Ministry of Health of New Zealand.. Wellington, New Zealand: Institute of Environmental Science and Research Limited (ESR); 1998.
  21. Tassew Z, Chandravanshi BS. Levels of nicotine in Ethiopian tobacco leaves.. Springerplus 2015;4(1):649.
    doi: 10.1186/s40064-015-1448-ygoogle scholar: lookup
  22. Park SB, Jacob P 3rd, Benowitz NL, Cashman JR. Stereoselective metabolism of (S)-(−)-nicotine in humans: formation of trans-(S)-(−)-nicotine N-1′-oxide.. Chem Res Toxicol 1993;6(6):880-888.
    doi: 10.1021/tx00036a019google scholar: lookup

Citations

This article has been cited 2 times.
  1. Ishii H, Shibuya M, Kusano K, Sone Y, Kamiya T, Wakuno A, Ito H, Miyata K, Sato F, Kuroda T, Yamada M, Leung GN. Generic approach for the discovery of drug metabolites in horses based on data-dependent acquisition by liquid chromatography high-resolution mass spectrometry and its applications to pharmacokinetic study of daprodustat.. Anal Bioanal Chem 2022 Nov;414(28):8125-8142.
    doi: 10.1007/s00216-022-04347-2pubmed: 36181513google scholar: lookup
  2. Ishii H, Shibuya M, Kusano K, Sone Y, Kamiya T, Wakuno A, Ito H, Miyata K, Sato F, Kuroda T, Yamada M, Leung GN. Pharmacokinetic Study of Vadadustat and High-Resolution Mass Spectrometric Characterization of its Novel Metabolites in Equines for the Purpose of Doping Control.. Curr Drug Metab 2022;23(10):850-865.